ArticleJournal of surgical case reports2026
A case of descending colon cancer achieving a complete response with preoperative capecitabine plus oxaliplatin therapy following colorectal stenting.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 71-year-old woman with obstructive descending colon cancer and synchronous lymph node and liver metastases underwent colorectal stenting to relieve colonic obstruction. Preoperative capecitabine plus oxaliplatin (CapeOX) was administered for four cycles. Subsequent imaging showed marked shrinkage of the primary tumor, with nodal and hepatic lesions no longer detectable. Laparoscopic left hemicolectomy was then performed. Histopathological examination demonstrated a pathological complete response (CR), with no viable tumor cells in the primary lesion and no lymph node metastasis. Postoperative chemotherapy was resumed, and the patient remains recurrence-free. This rare case highlights a CR in both primary and metastatic lesions after colorectal stenting and preoperative CapeOX therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.